MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Clinical trials for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MULTI-DRUG RESISTANT NEPHROTIC SYNDROME trials appear
Sign up with your email to follow new studies for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment using specially engineered immune cells (CAR-NK cells) in 36 children with B-cell-related autoimmune diseases like lupus and IgA nephropathy. The goal is to see if these cells can safely control the disease by targeting and calming the…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Engineered immune cells take aim at autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new treatment for people with certain autoimmune diseases like lupus and kidney disease. The treatment uses specially engineered immune cells (CAR T-cells) that target and attack faulty immune cells causing the disease. The main goal is to chec…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Engineered immune cells aim to tame autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment called QT-219C, which uses specially engineered immune cells (CAR-T cells) to target and destroy faulty B cells that cause autoimmune diseases like lupus and kidney disease. The treatment involves a one-time infusion after a short chem…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 08, 2026 12:02 UTC